StockWatch
·
Pharmaceuticals
Quarterly Result19 May 2026, 05:31 pm

Zim Laboratories: Standalone & Consolidated Results for FY26

AI Summary

Zim Laboratories Ltd has announced its audited standalone and consolidated financial results for the year ended March 31, 2026. The announcement follows a Board of Directors meeting held on May 19, 2026, where the results were reviewed and approved. Deloitte Haskins & Sells LLP issued an unmodified opinion on the financial results. The results are compliant with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Highlights

  • Audited standalone and consolidated financial results for FY26 approved.
  • Deloitte Haskins & Sells LLP issued an unmodified auditor's report.
  • Results comply with SEBI (LODR) Regulations, 2015.
  • Board meeting was held on May 19, 2026 to approve results.